Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 156-51-4 Chemical Structure| 156-51-4

Structure of Phenelzine sulfate
CAS No.: 156-51-4

Chemical Structure| 156-51-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Phenelzine sulfate is a non-selective and irreversible monoamine oxidase inhibitor (MAOI), used as an antidepressant and anxiolytic.

Synonyms: Phenelzine (sulfate); W-1544A; NSC 170957

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Phenelzine sulfate

CAS No. :156-51-4
Formula : C8H14N2O4S
M.W : 234.27
SMILES Code : NNCCC1=CC=CC=C1.O=S(O)(O)=O
Synonyms :
Phenelzine (sulfate); W-1544A; NSC 170957
MDL No. :MFCD00050687

Safety of Phenelzine sulfate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P280-P305+P351+P338
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse adipocytes 1 mM 120 minutes Inhibited insulin-stimulated glucose incorporation into lipids Br J Pharmacol. 2018 Jun;175(12):2428-2440
Rat liver membranes 100 µM 30 minutes Assess irreversible binding of phenelzine to I2 imidazoline receptors; results showed no change in total density Br J Pharmacol. 1995 Feb;114(4):837-45
Rat cerebral cortex membranes 100 µM 30 minutes Assess irreversible binding of phenelzine to I2 imidazoline receptors; results showed no change in total density Br J Pharmacol. 1995 Feb;114(4):837-45
Salmonella Enteritidis str. 1 30 µM 48 hours Inhibits TYR oxidoreductase activity, significantly inhibiting bacterial growth Pathogens. 2021 Apr 13;10(4):469
Rat brain cortical mitochondria 3, 10, 30 µM 5 minutes Phenelzine pretreatment significantly prevented mitochondrial dysfunction and oxidative modification of mitochondrial proteins induced by 4-HNE or ACR in a concentration-related manner. J Neurotrauma. 2017 Apr 1;34(7):1302-1317

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Mice fed a standard chow Oral 0.028% drinking solution 12 weeks Reduced body fat content without affecting cardiovascular function Br J Pharmacol. 2018 Jun;175(12):2428-2440
Sprague-Dawley rats Controlled cortical impact TBI model Subcutaneous injection 10 mg/kg initial dose, followed by 5 mg/kg maintenance doses every 12 hours Initial dose at 15 min post-TBI, followed by repeated doses every 12 h out to 60 h Phenelzine treatment significantly attenuated mitochondrial respiratory dysfunction at 72 h post-injury and significantly increased cortical tissue sparing. J Neurotrauma. 2017 Apr 1;34(7):1302-1317
C57BL/6 male mice High-sucrose-drinking mice Oral 102 µmol/kg/day Daily for 11 weeks Evaluate the metabolic effects of Phenelzine in high-sucrose-drinking mice, including body weight, fat accumulation, blood glucose and insulin levels. Int J Mol Sci. 2018 Sep 25;19(10):2904
Sprague-Dawley rats Chronic depression model Intraperitoneal injection 1-20 mg/kg Every 12 h for 7 days Evaluate phenelzine's modulation of I2 imidazoline receptors in brain and liver; results showed significant down-regulation of receptor density Br J Pharmacol. 1995 Feb;114(4):837-45
Mice Bleomycin-induced lung injury model Intraperitoneal injection 750 μg/head Administered at −1, 1, and 3 dpi Ameliorated bleomycin-decreased SpO2 levels and markedly reduced lung fibrosis with restored AT1 cell repopulation Nat Commun. 2024 Oct 24;15(1):9169

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01944657 1. Major Depressive Disorder Not Applicable Withdrawn(unable to enroll sub... More >>jects) Less << December 2015 United States, Maryland ... More >> Sheppard Pratt Health System Towson, Maryland, United States, 21204 Less <<
NCT01253642 Hormone-Resistant Prostate Can... More >>cer Metastatic Prostatic Adenocarcinoma Prostate Adenocarcinoma Recurrent Prostate Carcinoma Less << Phase 2 Terminated(low enrollment) - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01253642 - Terminated(low enrollment) - -
NCT02217709 Adenocarcinoma of the Prostate... More >> Recurrent Prostate Cancer Stage I Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer Less << Phase 2 Recruiting September 8, 2020 United States, California ... More >> USC Norris Westside Cancer Center Recruiting Beverly Hills, California, United States, 90211 Contact: Olga Castellanos    310-272-7653    ocastell@usc.edu    Principal Investigator: Mitchell E. Gross          Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Bartolo Santos, RN    323-409-4363    Bartolo.santos@med.usc.edu    Principal Investigator: Mitchell E. Gross, MD          Principal Investigator: Jean C. Shih, PhD          USC Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Charis Barg, RN    323-865-0464    Charis.barg@med.usc.edu    Principal Investigator: Mitchell E. Gross, MD          Principal Investigator: Jean C. Shih, PhD          Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Charis Barg, RN    323-865-0464    Charis.barg@med.usc.edu    Principal Investigator: Mitchell E. Gross, MD          Principal Investigator: Jean C. Shih, MD Less <<
NCT03505528 Metastatic Breast Cancer Phase 1 Recruiting May 20, 2019 Australia, Australian Capital ... More >>Territory Canberra Region Cancer Centre Recruiting Canberra, Australian Capital Territory, Australia, 260 Contact: Desmond Yip, MBBS    +61 2 6244 2220    desmond.yip@act.gov.au    Contact: Laeeq Malik, MBBS    +61 2 6244 2220    laeeq.malik@act.gov.au    Australia, New South Wales Southern Medical Day Care Centre Recruiting Wollongong, New South Wales, Australia, 2500 Contact: Philip Clingan, MBBS    +61 2 4227 3733    philipc@uow.edu.au    Contact: Margaret Clingan    +61 2 4227 3733    margaret@smdcc.com.au Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.27mL

0.85mL

0.43mL

21.34mL

4.27mL

2.13mL

42.69mL

8.54mL

4.27mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories